Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0716 CHF | +4.99% | +3.47% | +55.65% |
May. 08 | Addex to Present at BioEURquity Europe 2024 | DJ |
Apr. 30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
Sales 2024 * | 1.5M 1.66M | Sales 2025 * | 1.5M 1.66M | Capitalization | 9.18M 10.17M |
---|---|---|---|---|---|
Net income 2024 * | -4M -4.43M | Net income 2025 * | -3M -3.32M | EV / Sales 2024 * | 6.21 x |
Net Debt 2024 * | 138K 152K | Net Debt 2025 * | 2.27M 2.52M | EV / Sales 2025 * | 7.64 x |
P/E ratio 2024 * |
-1.19
x | P/E ratio 2025 * |
-1.43
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 49.45% |
Latest transcript on Addex Therapeutics Ltd
1 day | +4.99% | ||
1 week | +3.47% | ||
1 month | +17.38% | ||
3 months | +10.15% | ||
6 months | +66.51% | ||
Current year | +55.65% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.0716 | +4.99% | 28,821 |
24-05-30 | 0.0682 | +3.33% | 708,410 |
24-05-29 | 0.066 | -2.37% | 247,010 |
24-05-28 | 0.0676 | -7.14% | 522,245 |
24-05-27 | 0.0728 | +5.20% | 114,095 |
Delayed Quote Swiss Exchange, May 31, 2024 at 11:30 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.65% | 10.16M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ADXN Stock